Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Autophagy and Endoplasmic Reticulum Stress in HFpEF
Author(s): Citrawati Dyah Kencono Wungu , Hendri Susilo , Cleodylon Reinard Susanto , et al Added: 1 month ago

MI/ACS

Prevention & Chronic Conditions
ECG Exercise Stress Test in Coronary Artery Disease
Author(s): Gaetano Antonio Lanza Added: 10 months ago

Guidelines & Statements
Oxidative Stress Genes Predict Survival in STEMI
Author(s): Shuo-wen Sun , Xing-jie Wang , Ruo-chen Yan , et al Added: 11 months ago

MI/ACS

Prevention & Chronic Conditions
Echo-stress in Myocardial Bridge
Author(s): Priscilla Lamendola , Nello Cambise , Antonio Di Renzo , et al Added: 1 year ago

Prevention & Chronic Conditions
Author(s): Priscilla Lamendola , Nello Cambise , Antonio Di Renzo , et al Added: 1 year ago

Prevention & Chronic Conditions
Lp(a) and Atherosclerosis
Author(s): Annalisa Filtz , Leandro Slipczuk , Martha Gulati Added: 1 month ago

Prevention & Chronic Conditions
Development of Small-molecule SERCA Stimulators
Author(s): Antonio Zaza , Marcella Rocchetti Added: 9 months ago

Heart Failure
Job title: MD Icahn School of Medicine at Mount Sinai, New York, NY, USA
Dr Hajjar is the Director of the Cardiovascular Research Center and the Arthur and Janet C Ross Professor of Medicine at the Mount Sinai School of Medicine. His research focuses on molecular mechanisms of heart failure (HF) and his team has validated the cardiac sarcoplasmic reticulum calcium ATPase pump (SERCA2a) as a target in HF, developed methodologies for cardiac-directed gene therapy,… View more
MicroRNAs for Cardiac Regeneration
Author(s): Camilla Olianti , Mauro Giacca Added: 6 months ago

Prevention & Chronic Conditions

Heart Failure
iMODERN: No Benefit for Immediate Nonculprit-Lesion PCI
Added: 1 month ago Source:  ICR3 Journal Radcliffe Cardiology
The optimal timing for treating nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a topic of clinical debate. The iMODERN trial sought to clarify this by comparing outcomes between an immediate, physiology-guided percutaneous coronary intervention (PCI) strategy and a deferred, imaging-guided approach.¹˒²MethodologyThe… View more

Intervention

MI/ACS